☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Harmony Biosciences
Harmony Biosciences Collaborates with Bioprojet to Develop TPM-1116 as a Treatment of Narcolepsy and Other Sleep/Wake Disorders
April 12, 2024
Harmony Biosciences to Acquire Zynerba for ~$200M
August 17, 2023
Harmony Biosciences Reports the Initiation of P-III (INTUNE) Withdrawal Study for Pitolisant to Treat Idiopathic Hypersomnia
April 28, 2022
Insights+: The US FDA New Drug Approvals in August 2019
September 20, 2019
Load more...
Back to Home